Q1 2024 · 13F-HR
NEA Management Company, LLCholdings as filed
Filed 2024-05-15 · accession 0001012975-24-000231
$1.61B
Reported value
44
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $260.5M | 16.2% | 3,745,262 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $180.4M | 11.2% | 1,587,854 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $126.1M | 7.83% | 2,909,956 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $121.9M | 7.56% | 24,471,264 | Common | SOLE |
| 22266M104 | COUR | COURSERA INC | $108.2M | 6.72% | 12,867,769 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $96.6M | 5.99% | 1,072,936 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $89.9M | 5.58% | 5,108,563 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $54.2M | 3.37% | 7,692,298 | Common | SOLE |
| 65345N106 | NN | NEXTNAV INC | $53.9M | 3.34% | 8,189,156 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $43.2M | 2.68% | 2,370,542 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $42.2M | 2.62% | 12,776,409 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $39.2M | 2.44% | 11,370,376 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $38.6M | 2.39% | 3,568,781 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $27.0M | 1.68% | 1,250,001 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $27.0M | 1.68% | 17,079,778 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS INC | $22.6M | 1.40% | 4,448,757 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $20.8M | 1.29% | 14,986,793 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $20.8M | 1.29% | 1,960,169 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $20.6M | 1.28% | 1,500,000 | Common | SOLE |
| 98955G103 | — | ZEROFOX HLDGS INC | $20.2M | 1.26% | 18,068,513 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $19.9M | 1.23% | 3,969,834 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $18.7M | 1.16% | 15,838,009 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $18.7M | 1.16% | 2,437,689 | Common | SOLE |
| 75915K200 | — | REGULUS THERAPEUTICS INC | $18.6M | 1.16% | 6,467,802 | Common | SOLE |
| 10920V404 | — | NEUEHEALTH INC | $17.7M | 1.10% | 2,726,917 | Common | SOLE |
| 25058X105 | — | DESKTOP METAL INC | $12.7M | 0.79% | 14,407,594 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $11.5M | 0.71% | 3,835,039 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $10.8M | 0.67% | 2,000,275 | Common | SOLE |
| 90114C107 | TUYA | TUYA INC | $8.6M | 0.54% | 4,934,640 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $8.4M | 0.52% | 1,713,720 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $7.9M | 0.49% | 4,785,494 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $7.7M | 0.48% | 6,147,260 | Common | SOLE |
| 12430A102 | — | BUZZFEED INC | $7.2M | 0.44% | 15,333,892 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $5.7M | 0.35% | 2,382,286 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $5.3M | 0.33% | 1,462,586 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $5.2M | 0.32% | 2,922,772 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $4.6M | 0.29% | 1,071,428 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED NV | $2.3M | 0.15% | 442,649 | Common | SOLE |
| 81726A100 | — | SENTI BIOSCIENCES INC | $1.7M | 0.10% | 4,426,151 | Common | SOLE |
| 628988107 | MYND | MYND AI INC | $1.6M | 0.10% | 3,642,711 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $926,211 | 0.06% | 419,100 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $809,471 | 0.05% | 570,050 | Common | SOLE |
| 96328L205 | 2CH | WHEELS UP EXPERIENCE INC | $304,579 | 0.02% | 106,125 | Common | SOLE |
| 868927104 | — | SURF AIR MOBILITY INC | $185,637 | 0.01% | 220,209 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.